$BCRX
BioCryst Pharmaceuticals Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$7.75
▼-3.37%-$0.270
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBioCryst Pharmaceuticals Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is BCRX down today? It is at $7.75 (-3.37%), and our scanner flagged it 85 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BCRX spikes, and full due diligence on BCRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BCRX 85 times in the last 30 days. Create a free account to track $BCRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BCRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BCRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystBIOCRYST PHARMACEUTICALS INC: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 2, 2026 · 44 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Frank Steven Director | Acquired (grant/award) | +1K | added 3.6% | 37K | $12K at $9.70 | Aug 31, 26 |
Mckee Amy E Director | Acquired (grant/award) | +644 | added 1.4% | 48K | $6K at $9.70 | Aug 31, 26 |
Milano Vincent Director | Acquired (grant/award) | +1K | added 1.1% | 110K | $11K at $9.70 | Aug 31, 26 |
Milne Jill C. Director | Acquired (grant/award) | +1K | added 4.0% | 33K | $12K at $9.70 | Aug 31, 26 |
Stonehouse Jon P Director | Acquired (grant/award) | +644 | added <0.1% | 1.34M | $6K at $9.70 | Aug 31, 26 |
Heggie Theresa Director | Acquired (grant/award) | +15K | added 23% | 81K | n/a | Jun 11, 26 |
Mckee Amy E Director | Acquired (grant/award) | +15K | added 48% | 47K | n/a | Jun 11, 26 |
Stonehouse Jon P Director | Acquired (grant/award) | +15K | added 1.2% | 1.34M | n/a | Jun 11, 26 |
Milano Vincent Director | Acquired (grant/award) | +15K | added 16% | 108K | n/a | Jun 11, 26 |
Sanders Machelle Director | Acquired (grant/award) | +15K | added 50% | 46K | n/a | Jun 11, 26 |
Frank Steven Director | Acquired (grant/award) | +15K | added 76% | 35K | n/a | Jun 11, 26 |
Levin Alan G Director | Acquired (grant/award) | +15K | added 24% | 80K | n/a | Jun 11, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on BCRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BCRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
BCRX last traded at $7.75, down 3.37% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
BioCryst Pharmaceuticals Inc (BCRX) is next expected to report earnings on Monday, November 2, 2026, about 16 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BCRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BCRX 85 times in the last 30 days.
BCRX (BioCryst Pharmaceuticals Inc) trades on XNAS, with a market cap of about $1.99B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BCRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BCRX discussion
Sign in to ask a question or join the discussion.